About US
Contact us
-
Special Recognition Accolade posthumously awarded to Sir Allen McClay, Founder of AlmacAlmac Group agrees to mentor the winner of the ‘Sir Allen McClay Young Business Person of the Year’ award Almac, the international, integrated contract development and manufacturing organisation, h2010/6/24
-
Prosensa and GlaxoSmithKline initiate development of four additional products under existing alliance in Duchenne Muscular DystrophyBroadened program marks key inflexion in Prosensa’s progress to a fully integrated specialty-pharma company Leiden, Netherlands, June 23th, 2010 – Prosensa, the Dutch biopharmaceutical company fo2010/6/24
-
COMSOL Announces Chemical Reaction Engineering ModuleCOMSOL Inc, the developer of the market leading COMSOL Multiphysics simulation environment, today releases the Chemical Reaction Engineering Module. This new module is built on the COMSOL platform to2010/6/23
-
Examination Criteria for Catering Services Licensing issuedIn order to carry out the classification management of catering services licensing and standardize the catering services licensing, the State Food and Drug Administration issued Examination Cr2010/6/23
-
BASF’s plastic segment to grow more profitably and faster than the market· Investment in new plants, research and capacity expansions planned · High proportion of specialty plastics increases BASF’s cyclical resilience Ludwigshafen, Germany – June 22, 2010 – BASF aims2010/6/23
-
SBS Biomolecular Screening SymposiumSBS Biomolecular Screening SymposiumAdvanced Applications Across Academia, Government & IndustryOctober 18 -19, 2010 - Sheraton Imperial Hotel & Convention CenterDurham, NC, USAwww.sbsonline.o2010/6/22
-
Improving Solubility for Pharmaceuticals & Biologics 2010In the current economic climate, there is more pressure than ever before to ensure that pharmaceutical and biopharmaceutical drug candidates are developed into target effective and profit-making drugs2010/6/21
-
New Data Presented From EMBLEM™ Study For Pipeline Drug Epratuzumab For Patients Suffering From Moderate To Severe Systemic Lupus ErythematosusTreatment differences were observed as early as week 8, with further improvement to week 12 Epratuzumab 600 mg weekly was associated with greater BILAG improvement than placebo in affected body sy2010/6/21
-
Sparta Systems Unveils TrackWise Software Version 8Sparta Systems., Inc., the maker of TrackWise® software and the market leader in enterprise quality and compliance management solutions, recently announced the general availability of Version 8 of2010/6/21
-
Lonza Introduces Applied Protein Services Preclinical Platform To Improve Biologic Development SuccessLonza, a leader in biopharmaceutical development services and contract manufacturing, is launching a new set of immunogenicity, stability and protein engineering services to benefit customers. The new2010/6/18